Andrea Visentin

2.9k total citations
100 papers, 994 citations indexed

About

Andrea Visentin is a scholar working on Genetics, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Andrea Visentin has authored 100 papers receiving a total of 994 indexed citations (citations by other indexed papers that have themselves been cited), including 76 papers in Genetics, 41 papers in Immunology and 40 papers in Pathology and Forensic Medicine. Recurrent topics in Andrea Visentin's work include Chronic Lymphocytic Leukemia Research (72 papers), Lymphoma Diagnosis and Treatment (39 papers) and Immunodeficiency and Autoimmune Disorders (21 papers). Andrea Visentin is often cited by papers focused on Chronic Lymphocytic Leukemia Research (72 papers), Lymphoma Diagnosis and Treatment (39 papers) and Immunodeficiency and Autoimmune Disorders (21 papers). Andrea Visentin collaborates with scholars based in Italy, United States and Spain. Andrea Visentin's co-authors include Livio Trentin, Chiara Briani, Gianpietro Semenzato, Federica Frezzato, Francesco Piazza, Monica Facco, Valentina Trimarco, Filippo Severin, Veronica Martini and Alessandro Salvalaggio and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andrea Visentin

89 papers receiving 986 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrea Visentin Italy 20 535 322 270 242 206 100 994
Nathan De Beule Belgium 11 302 0.6× 220 0.7× 165 0.6× 252 1.0× 170 0.8× 22 747
Nathalie Gachard France 18 354 0.7× 397 1.2× 565 2.1× 311 1.3× 463 2.2× 57 1.3k
Catherine Richon France 18 233 0.4× 243 0.8× 110 0.4× 608 2.5× 391 1.9× 32 1.2k
Shahrzad Jalali United States 17 196 0.4× 383 1.2× 213 0.8× 199 0.8× 406 2.0× 39 952
Marc Shuman United States 11 259 0.5× 62 0.2× 317 1.2× 396 1.6× 186 0.9× 20 1.1k
Tohru Miki Japan 12 149 0.3× 334 1.0× 284 1.1× 262 1.1× 223 1.1× 28 832
Hari P. Miskin United States 15 699 1.3× 297 0.9× 676 2.5× 262 1.1× 315 1.5× 66 1.1k
Rogier Mous Netherlands 11 174 0.3× 245 0.8× 308 1.1× 155 0.6× 392 1.9× 35 723
Veronica Martini Italy 19 308 0.6× 315 1.0× 175 0.6× 281 1.2× 150 0.7× 41 740
Tammy Price-Troska United States 17 522 1.0× 374 1.2× 481 1.8× 835 3.5× 544 2.6× 34 1.6k

Countries citing papers authored by Andrea Visentin

Since Specialization
Citations

This map shows the geographic impact of Andrea Visentin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrea Visentin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrea Visentin more than expected).

Fields of papers citing papers by Andrea Visentin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrea Visentin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrea Visentin. The network helps show where Andrea Visentin may publish in the future.

Co-authorship network of co-authors of Andrea Visentin

This figure shows the co-authorship network connecting the top 25 collaborators of Andrea Visentin. A scholar is included among the top collaborators of Andrea Visentin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrea Visentin. Andrea Visentin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bonaldi, Laura, et al.. (2025). Management strategies for patients with chronic lymphocytic leukaemia harbouring complex karyotype. British Journal of Haematology. 206(3). 832–841.
2.
Visentin, Andrea, et al.. (2024). Innovative Combinations, Cellular Therapies and Bispecific Antibodies for Chronic Lymphocytic Leukemia: A Narrative Review. Cancers. 16(7). 1290–1290. 4 indexed citations
3.
Pizzi, Marco, Federico Scarmozzino, Luisa Santoro, et al.. (2024). CD23 expression in lymphoplasmacytic lymphoma: Clinical–pathological and biological correlations. Histopathology. 86(6). 942–952.
4.
Bonaldi, Laura, Roberta Bertorelle, Sabrina Manni, et al.. (2024). Impact of the presence and number of chromosomal abnormalities on the clinical outcome in Waldenström Macroglobulinemia: a monocentric experience. Annals of Hematology. 103(8). 2961–2968. 1 indexed citations
5.
Prete, Dorella Del, Tamara Berno, Andrea Visentin, et al.. (2024). When Waldenström macroglobulinemia hits the kidney: Description of a case series and management of a “rare in rare” scenario. Cancer Reports. 7(4). e2062–e2062. 1 indexed citations
6.
Frezzato, Federica, Laura Bonaldi, Stefano Pravato, et al.. (2024). Exploring the prognostic role of complex karyotype in chronic lymphocytic leukaemia patients treated with venetoclax‐based regimens. British Journal of Haematology. 205(1). 189–193. 1 indexed citations
7.
8.
9.
Mauro, Francesca Romana, Anna Maria Frustaci, Andrea Visentin, et al.. (2024). Severe infections in patients with chronic lymphocytic leukemia included in trials investigating BTK and BCL2 inhibitors. Critical Reviews in Oncology/Hematology. 201. 104408–104408. 1 indexed citations
10.
Salvalaggio, Alessandro, Elisa Vegezzi, Andrea Visentin, et al.. (2023). Caspr1 antibodies autoimmune paranodopathy with severe tetraparesis: Potential relevance of antibody titers in monitoring treatment response. Journal of the Peripheral Nervous System. 28(3). 522–527. 7 indexed citations
11.
Grassi, Angela, Tamara Berno, Andrea Visentin, et al.. (2023). Waldenström Macroglobulinemia in Very Elderly (≥75-year-old) Patients: A 33-year-retrospective Cohort Study in an Italian University Hospital. HemaSphere. 7(10). e964–e964. 3 indexed citations
12.
Briani, Chiara, Sérgio Ferrari, Tamara Berno, et al.. (2023). Peripheral neuropathy as clinical onset of monoclonal IgM/k‐related amyloidosis. Journal of the Peripheral Nervous System. 28(2). 262–265. 2 indexed citations
13.
Severin, Filippo, Andrea Visentin, Elisa Pagnin, et al.. (2023). Focal adhesion kinase activation by calcium‐dependent calpain is involved in chronic lymphocytic leukaemia cell aggressiveness. British Journal of Haematology. 203(2). 224–236. 5 indexed citations
14.
Visentin, Andrea, Stefano Pravato, Silvia Imbergamo, et al.. (2022). A Retrospective Study on the Efficacy of Subcutaneous Immunoglobulin as Compared to Intravenous Formulation in Patients with Chronic Lymphocytic Leukemia and Secondary Antibody Deficiency. Current Oncology. 30(1). 274–283. 9 indexed citations
15.
Frezzato, Federica, Andrea Visentin, Filippo Severin, et al.. (2021). Targeting of HSP70/HSF1 Axis Abrogates In Vitro Ibrutinib-Resistance in Chronic Lymphocytic Leukemia. Cancers. 13(21). 5453–5453. 6 indexed citations
16.
Cappuzzello, Elisa, Andrea Visentin, Giuseppe Astori, et al.. (2021). Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells. Journal for ImmunoTherapy of Cancer. 9(7). e002475–e002475. 11 indexed citations
17.
Visentin, Andrea, Silvia Imbergamo, Valentina Trimarco, et al.. (2020). Ibrutinib in relapsed hairy cell leukemia variant: A case report and review of the literature. Hematological Oncology. 38(5). 823–826. 15 indexed citations
18.
Nadali, Gianpaolo, Anna Candoni, Chiara Cattaneo, et al.. (2020). Infections in patients with lymphoproliferative diseases treated with brentuximab vedotin: SEIFEM multicentric retrospective study. Leukemia & lymphoma. 61(12). 3002–3005. 1 indexed citations
19.
Piazza, Francesco, et al.. (2019). New responsibilities for aged kinases in B‐lymphomas. Hematological Oncology. 38(1). 3–11. 8 indexed citations
20.
Visentin, Andrea, Monica Facco, Carmela Gurrieri, et al.. (2019). Prognostic and Predictive Effect of IGHV Mutational Status and Load in Chronic Lymphocytic Leukemia: Focus on FCR and BR Treatments. Clinical Lymphoma Myeloma & Leukemia. 19(10). 678–685.e4. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nathan De Beule Breakdown of academic impact, for papers by Nathalie Gachard Breakdown of academic impact, for papers by Catherine Richon Breakdown of academic impact, for papers by Shahrzad Jalali Breakdown of academic impact, for papers by Marc Shuman Breakdown of academic impact, for papers by Tohru Miki Breakdown of academic impact, for papers by Hari P. Miskin Breakdown of academic impact, for papers by Rogier Mous Breakdown of academic impact, for papers by Veronica Martini Breakdown of academic impact, for papers by Tammy Price-Troska
Rankless by CCL
2026